ATLASSolid Biosciences (SLDB) earnings date: Nov 2, 2026
Solid Biosciences (SLDB) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 2, 2026, after the close. Analysts expect EPS of -$0.37.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on SLDB
| Last price | $6.20 (-3.0%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.5% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Solid Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Solid Biosciences reports on Nov 2, 2026. One email the day before, with ATLAS’s read on Solid Biosciences. You can switch it off at any time.
Alert me before SLDB reportsFree to start. Creating an account takes under a minute.
SLDB earnings at a glance
| Next report (confirmed) | Mon, Nov 2, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.37 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +22.5% |
| Average move around a report | ±5.2% (last 5) |
| Sector | Healthcare · Biotechnology |
Solid Biosciences earnings history: last 5 reports
Solid Biosciences last reported on Aug 6, 2026: EPS of -$0.38 against an estimate of -$0.47 (+19.2% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.47 | -$0.38 | +19.2% | Beat | -3.9% |
| Apr 2, 2026 | -$0.62 | -$0.71 | -14.5% | Miss | +4.9% |
| Mar 19, 2026 | -$0.52 | -$0.53 | -1.9% | In line | -1.3% |
| Feb 6, 2026 | $3.18 | $6.15 | +93.4% | Beat | +10.1% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -6.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SLDB
See the fair value, the probability range and the earnings history of Solid Biosciences on its ATLAS page.
Solid Biosciences (SLDB) stock analysisPlans from €3.99 a month.
Solid Biosciences earnings: frequently asked questions
When does Solid Biosciences (SLDB) report earnings?
Solid Biosciences is scheduled to report on Monday, November 2, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SLDB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.37 per share (USD). Estimates can change before the report.
How often does SLDB beat earnings estimates?
Of its last 5 reports with a recorded result, Solid Biosciences beat the EPS estimate 3 times; the average surprise was +22.5%. Past results do not predict the next one.
How much does SLDB move around earnings?
Over its last 5 reports the stock moved an average of 5.2% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Solid Biosciences beat earnings estimates last quarter?
Solid Biosciences last reported on Aug 6, 2026: EPS of -$0.38 against an estimate of -$0.47 (+19.2% surprise), a beat.
How much does SLDB usually move in a day?
On a normal trading day the ATLAS model puts SLDB’s one-day range at about ±4.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 2, 2026
Educational information, not investment advice. Disclaimer